Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

108.78 USD +0.09 (+0.08%)
Streaming Delayed Price Updated: 8:17 AM EST, Feb 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,663
Open 108.69
Bid (Size) 108.69 (1)
Ask (Size) 108.90 (8)
Prev. Close 108.69
Today's Range 108.69 - 108.99
52wk Range 62.55 - 113.41
Shares Outstanding 1,586,879,451
Dividend Yield 3.30%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Allergan, an AbbVie Company, Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia
- If approved, this is expected to be the first eye drop to treat presbyopia 
From PR Newswire
HUMIRA® (adalimumab) Receives FDA Approval to Treat Pediatric Patients Living with Moderately to Severely Active Ulcerative Colitis
- HUMIRA (adalimumab) is the first and only subcutaneous biologic treatment option for pediatric patients from 5 years of age with moderately to severely active ulcerative colitis[1] 
From PR Newswire

Performance

YTD
+3.20%
+3.20%
1 Month
-1.56%
-1.56%
3 Month
+4.40%
+4.40%
6 Month
+15.29%
+15.29%
1 Year
+21.98%
+21.98%

More News

Read More
New REFRESH® DIGITAL Lubricant Eye Drops Tackle Eye Dryness Due to Everyday Screen Use
From PR Newswire
Second Phase 3 Induction Study Confirms Upadacitinib (RINVOQ™) Improved Clinical, Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients
From PR Newswire
AbbVie's Humira Gets FDA Approval For Pediatric Ulcerative Colitis
Tags Benzinga ulcerative colitis Market News
From Benzinga
AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property Litigation
From PR Newswire
How to Invest Like Warren Buffett in 2021
Tags CVX RH SSP
From Motley Fool
AbbVie's Upadacitinib Shows Clinical Benefit In Second Late-Stage Ulcerative Colitis Study
Tags Phase 3 Study ABBV After/Hours Center
From Benzinga
Cathie Wood Couldn't Stop Buying These 3 Stocks for ARK Invest Last Week
Tags ARKW ARKQ TDOC
From Motley Fool
2 Best Pharma Stocks to Buy Right Now
Tags Market News MYL ABBV
From Motley Fool
Warren Buffett Just Gave Himself a $565 Million "Raise"
Tags BRK/B VZ CVX
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.